All SEC Filings :: Syros Pharmaceuticals, Inc. (SYRS)

Filing Type:

Year:

Date	Form	Description	Pages
08/12/24	8-K	Current report filing Documents EX-99.1	5
08/02/24	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Documents EX-99.1	21
07/31/24	S-8	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Documents EX-5.1 EX-23.2 EX-FILING FEES	6
07/31/24	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-3.1 EX-10.1 EX-10.2 EX-31.1 EX-31.2 EX-32.1 EX-32.2	191
07/02/24	4	Statement of changes in beneficial ownership of securities	1
06/28/24	144	Filing for proposed sale of securities under Rule 144	3
06/07/24	4	Statement of changes in beneficial ownership of securities	1
06/07/24	4	Statement of changes in beneficial ownership of securities	1
06/07/24	4	Statement of changes in beneficial ownership of securities	1
06/07/24	4	Statement of changes in beneficial ownership of securities	1